Pharmacologic mediators of bronchoconstriction.
作者信息
Parker C W
出版信息
Jpn J Pharmacol. 1980;30(Suppl):10P-13P.
PMID:6113295
Abstract
摘要
相似文献
1
Pharmacologic mediators of bronchoconstriction.
Jpn J Pharmacol. 1980;30(Suppl):10P-13P.
2
[Mast cells and arachidonic acid metabolism as central effectors of allergic bronchial obstruction].
Internist (Berl). 1985 Apr;26(4):182-94.
3
Leukotrienes and lung disease.
Thorax. 1982 Apr;37(4):241-5. doi: 10.1136/thx.37.4.241.
4
Mediators of anaphylaxis and inflammation.
Annu Rev Microbiol. 1982;36:371-413. doi: 10.1146/annurev.mi.36.100182.002103.
5
[Lipoxygenase catalyzation of arachidonic acid metabolism and the effect of its inhibition on anaphylactic reactions].
Pharmazie. 1986 Jan;41(1):7-22.
6
Leukotrienes: mediators of inflammation and immediate hypersensitivity reactions.
Crit Rev Immunol. 1984;4(4):307-34.
7
[Physiological and pharmacological actions of prostaglandins and related substances: inflammation and allergy].
Nihon Rinsho. 1985 Mar;43(3):523-8.
8
The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology.
J Clin Invest. 1984 Apr;73(4):889-97. doi: 10.1172/JCI111312.
9
SRS-A and other mediators. Slow reacting substance biosynthesis, characterization and purification.
Monogr Allergy. 1979;14:155-62.
10
Mediators of immediate hypersensitivity derived from arachidonic acid.
N Engl J Med. 1980 Oct 2;303(14):822-5. doi: 10.1056/NEJM198010023031421.
Zotero 插件